Precision Oncology Revenue and Competitors
Estimated Revenue & Valuation
- Precision Oncology's estimated annual revenue is currently $7M per year.
- Precision Oncology's estimated revenue per employee is $201,000
Employee Data
- Precision Oncology has 35 Employees.
- Precision Oncology grew their employee count by 6% last year.
Precision Oncology's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP, CLINICAL OPERATIONS - EUROPE | Reveal Email/Phone |
2 | SVP | Reveal Email/Phone |
3 | SVP | Reveal Email/Phone |
4 | SVP | Reveal Email/Phone |
5 | Project Director | Reveal Email/Phone |
6 | Senior Project Director | Reveal Email/Phone |
7 | Director Contract Management | Reveal Email/Phone |
8 | Chief Operating Officer | Reveal Email/Phone |
9 | Project Director | Reveal Email/Phone |
10 | Managing Director BIOMARKER AND IVD ANALYTICS | Reveal Email/Phone |
Precision Oncology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Precision Oncology?
ACT Oncology is an oncology specialty CRO with a clear and consistent focus on supporting cutting edge clinical research. We believe in the power of our Sponsors’ novel science, combined with our clinical operations expertise. As leaders in the application of metrics-driven project management to optimize global oncology clinical research, we offer a dedicated team of experts to ensure the success of each of our collaborations.
keywords:N/A
N/A
Total Funding
35
Number of Employees
$7M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Precision Oncology News
... improved greatly once Fejerman and her team added in the protective, ancestry-specific variants, Fejerman told Precision Oncology News.
Black Diamond Therapeutics is closing down at least one run at a precision oncology med after getting a glimpse of the rocky terrain ahead...
Pangea's ENLIGHT platform is designed to predict patient response to more than 100 oncology drugs that are designed to treat dozens of types...
Other Companies in Flemington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.8M | 36 | 6% | N/A |
#2 | $5M | 36 | 6% | N/A |
#3 | $3.5M | 38 | -5% | N/A |
#4 | $9.5M | 41 | -5% | N/A |
#5 | $7.2M | 43 | -4% | N/A |